Cassava Sciences Stock Buy Hold or Sell Recommendation
| SAVA Stock | USD 2.40 0.20 7.69% |
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Cassava Sciences is 'Strong Sell'. Macroaxis provides Cassava Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SAVA positions.
Check out Cassava Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide. In addition, we conduct extensive research on individual companies such as Cassava and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Cassava |
Execute Cassava Sciences Buy or Sell Advice
The Cassava recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cassava Sciences. Macroaxis does not own or have any residual interests in Cassava Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cassava Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
2 Years |
Risk Tolerance
I can tolerate above average risk |
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Cassava Sciences Trading Alerts and Improvement Suggestions
| Cassava Sciences generated a negative expected return over the last 90 days | |
| Cassava Sciences has high historical volatility and very poor performance | |
| Cassava Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (97.22 M) with loss before overhead, payroll, taxes, and interest of (67.84 M). | |
| Cassava Sciences currently holds about 197.23 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders |
Cassava Sciences Returns Distribution Density
The distribution of Cassava Sciences' historical returns is an attempt to chart the uncertainty of Cassava Sciences' future price movements. The chart of the probability distribution of Cassava Sciences daily returns describes the distribution of returns around its average expected value. We use Cassava Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cassava Sciences returns is essential to provide solid investment advice for Cassava Sciences.
| Mean Return | -0.49 |
| Value At Risk | -6.29 |
| Potential Upside | 8.17 |
| Standard Deviation | 4.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cassava Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cassava Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cassava Sciences or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cassava Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cassava stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.49 | |
β | Beta against Dow Jones | 0.23 | |
σ | Overall volatility | 4.95 | |
Ir | Information ratio | -0.1 |
Cassava Sciences Volatility Alert
Cassava Sciences exhibits very low volatility with skewness of 1.0 and kurtosis of 2.26. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cassava Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cassava Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cassava Sciences Fundamentals Vs Peers
Comparing Cassava Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cassava Sciences' direct or indirect competition across all of the common fundamentals between Cassava Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cassava Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cassava Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cassava Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cassava Sciences to competition |
| Fundamentals | Cassava Sciences | Peer Average |
| Return On Equity | -0.11 | -0.31 |
| Return On Asset | -0.46 | -0.14 |
| Current Valuation | 3.95 M | 16.62 B |
| Shares Outstanding | 48.11 M | 571.82 M |
| Shares Owned By Insiders | 12.75 % | 10.09 % |
| Shares Owned By Institutions | 36.56 % | 39.21 % |
| Number Of Shares Shorted | 15.94 M | 4.71 M |
| Price To Book | 0.75 X | 9.51 X |
| Gross Profit | (67.84 M) | 27.38 B |
| EBITDA | (95.69 M) | 3.9 B |
| Net Income | (97.22 M) | 570.98 M |
| Cash And Equivalents | 197.23 M | 2.7 B |
| Cash Per Share | 4.92 X | 5.01 X |
| Total Debt | 14.2 M | 5.32 B |
| Current Ratio | 23.41 X | 2.16 X |
| Book Value Per Share | 3.47 X | 1.93 K |
| Cash Flow From Operations | (82.03 M) | 971.22 M |
| Short Ratio | 11.80 X | 4.00 X |
| Earnings Per Share | (1.38) X | 3.12 X |
| Price To Earnings To Growth | (0.21) X | 4.89 X |
| Target Price | 116.0 | |
| Number Of Employees | 29 | 18.84 K |
| Beta | -0.95 | -0.15 |
| Market Capitalization | 115.47 M | 19.03 B |
| Total Asset | 151.66 M | 29.47 B |
| Retained Earnings | (380.77 M) | 9.33 B |
| Working Capital | 115.44 M | 1.48 B |
| Net Asset | 151.66 M |
Note: Acquisition by Richard Barry of 600000 shares of Cassava Sciences at 27.42 subject to Rule 16b-3 [view details]
Cassava Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cassava . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cassava Sciences Buy or Sell Advice
When is the right time to buy or sell Cassava Sciences? Buying financial instruments such as Cassava Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cassava Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 31 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cassava Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.